Our Mission

Proxima's mission is to unlock a new chapter in medicine by making protein interactions programmable

Inducers

Modulators

Blockers

An Integrated Discovery Platform

Three complementary, phase shifting technologies…

…built to unlock the full potential of the proximity modulator modality

Working With Industry Leaders

BUILD THE FUTURE WITH US

Latest News

March 5, 2026
Proxima Appoints Dr. Raymond Deshaies, Dr. Lyn Jones, and Dr. Juri Rappsilber to Scientific Advisory Board
New advisors bring decades of industry drug discovery leadership and foundational scientific expertise across Proxima's proximity therapeutics engine and structural proteomics data platform
January 13, 2026
Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines
Proxima closes an $80 million seed round backed by DCVC, Nvidia, and others to advance AI drug discovery with an advanced data generation platform.
August 19, 2025
Proxima and Halda Therapeutics Forge Alliance to Discover Next-Generation RIPTAC Medicines
Proxima and Halda Therapeutics today announced a strategic research collaboration worth over $1 billion in total potential value.

Generative AI in Drug Discovery Lecture Series

Dive into our premiere episodes of a monthly lecture series dedicated to Generative AI in Drug Discovery

About Us

If you are looking for a role at the bleeding edge of artificial intelligence, where your impact is immediate and meaningful, this is it.

Apply your skills to help us tackle some of the most complex and meaningful scientific challenges on the planet.